Vitamins and Coenzymes Practice Questions

Q: Which of the following is NOT seen in hypervitaminosis A?

Polyuria. **Explanation:** Hypervitaminosis A (Vitamin A toxicity) occurs due to the excessive intake of preformed Vitamin A (retinoids), leading to multi-systemic manifestations. **Why Polyuria is the Correct Answer:** **Polyuria** is not a feature of Vitamin A toxicity. Instead, polyuria and polydipsia are classic hallmarks of **Hypervitaminosis D**, where excessive calcium mobilization leads to hypercalcemia and a subsequent decrease in the kidney's concentrating ability (nephrogenic diabetes insipidus). **Analysis of Incorrect Options:** * **Alopecia:** Chronic Vitamin A toxicity leads to skin and mucosal changes, including dry, itchy skin, desquamation, and significant hair loss (alopecia). * **Pseudotumor Cerebri:** This is a high-yield association. Excess Vitamin A interferes with the resorption of cerebrospinal fluid (CSF), leading to increased intracranial pressure. Clinical signs include headache, papilledema, and cranial nerve palsies. * **Hyperlipidemia:** Retinoids stimulate the synthesis of triglycerides and VLDL in the liver, often leading to significant hypertriglyceridemia and hypercholesterolemia in toxic states. **NEET-PG High-Yield Pearls:** 1. **Teratogenicity:** Vitamin A is highly teratogenic (Category X); it can cause craniofacial abnormalities and cardiac defects in the fetus. Pregnancy must be ruled out before starting isotretinoin. 2. **Acute Toxicity:** Can present as "Polar Bear Liver" poisoning, characterized by sudden vomiting, headache, and vertigo. 3. **Bone Changes:** Chronic toxicity causes cortical thickening and painful hyperostosis. 4. **Storage:** Vitamin A is stored in the **Ito cells** (stellate cells) of the liver.

Q: How many mg of Tryptophan are required to produce 1 mg of Niacin?

60. **Explanation:** The correct answer is **60 mg**. This is a classic high-yield fact in biochemistry regarding the endogenous synthesis of Niacin (Vitamin B3). **1. Why 60 mg is correct:** In the human body, Niacin can be synthesized from the essential amino acid **Tryptophan** via the **Kynurenine pathway**. This process is relatively inefficient; it takes approximately **60 mg of dietary Tryptophan to produce 1 mg of Niacin**. This relationship is expressed as **1 Niacin Equivalent (NE) = 1 mg Niacin or 60 mg Tryptophan.** This pathway is crucial because it explains why populations consuming diets high in Tryptophan (like milk and eggs) do not develop Niacin deficiency, even if their direct Niacin intake is low. **2. Why other options are incorrect:** * **Options A (22), B (37), and C (55):** These values do not represent any established physiological conversion ratio for Niacin synthesis. They are distractors often used in exams to confuse students who may remember that a "large" number is required but cannot recall the specific 60:1 ratio. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Cofactors:** The conversion of Tryptophan to Niacin requires **Vitamin B6 (Pyridoxine)**, **Vitamin B2 (Riboflavin)**, and **Iron**. A deficiency in B6 can lead to secondary Niacin deficiency (Pellagra). * **Pellagra:** Characterized by the **4 Ds**: Dermatitis (Casal’s necklace), Diarrhea, Dementia, and Death. * **Hartnup Disease:** A genetic defect in the transport of neutral amino acids (including Tryptophan) in the gut and kidneys, leading to Pellagra-like symptoms due to decreased Tryptophan availability. * **Carcinoid Syndrome:** Can cause Niacin deficiency because Tryptophan is diverted away from Niacin synthesis to overproduce **Serotonin (5-HT)**.

Q: Which of the following acts as a cofactor after its modification?

Pantothenic acid. **Explanation** The correct answer is **Pantothenic acid (Vitamin B5)**. **Why Pantothenic Acid is Correct:** Most water-soluble vitamins act as precursors to coenzymes. Pantothenic acid itself is biologically inactive; it must undergo significant structural modification to become **Coenzyme A (CoA)** or **Acyl Carrier Protein (ACP)**. The synthesis involves phosphorylation and the addition of cysteine and ATP. These modified forms are essential for the metabolism of carbohydrates, lipids, and proteins, specifically in the transfer of acyl groups (e.g., Acetyl-CoA in the TCA cycle). **Analysis of Incorrect Options:** * **Vitamin C (Ascorbic Acid):** Unlike B-complex vitamins, Vitamin C acts as a cofactor in its **native state** (as a reducing agent). It does not require complex enzymatic conversion into a different molecule to function in hydroxylation reactions (e.g., collagen synthesis). * **Biotin (Vitamin B7):** While Biotin must be covalently linked to carboxylase enzymes (via a lysine residue to form Biocytin), it does not undergo a structural chemical modification of its core ring system to become active. It acts as a prosthetic group in its original form. * **Zinc:** This is a **trace element/mineral**, not a vitamin. It acts as a metallic cofactor (metalloprotein) directly in its ionic form ($Zn^{2+}$) without any chemical modification. **High-Yield Clinical Pearls for NEET-PG:** * **Burning Feet Syndrome:** The classic clinical deficiency associated with Pantothenic acid. * **Key Enzyme:** Pantothenate kinase is the rate-limiting enzyme in the conversion of Pantothenic acid to Coenzyme A. * **Mnemonic:** Remember "Pantothenic" sounds like "Penta" (5), representing Vitamin B5 and its role in the 5-carbon containing Coenzyme A.

Q: Which of the following does not have a role in regulating Vitamin D metabolism?

Lungs. **Explanation:** Vitamin D metabolism is a multi-step process involving specific organs that facilitate its synthesis and activation. The **Lungs (Option B)** do not play a physiological role in the metabolic pathway of Vitamin D, making it the correct answer. **Why the other options are involved:** * **Skin (Option D):** This is the site of synthesis. Under the influence of UV-B light, **7-dehydrocholesterol** is converted into **Cholecalciferol (Vitamin D3)**. * **Liver (Option A):** Cholecalciferol travels to the liver, where the enzyme **25-hydroxylase** converts it into **25-hydroxycholecalciferol [25(OH)D3]** or Calcidiol. This is the major storage form and the marker used to clinically assess Vitamin D status. * **Kidney (Option C):** This is the site of final activation. The enzyme **1-alpha-hydroxylase** (stimulated by PTH) converts 25(OH)D3 into **1,25-dihydroxycholecalciferol [1,25(OH)2D3]** or **Calcitriol**, which is the biologically active form. **High-Yield Clinical Pearls for NEET-PG:** 1. **Rate-limiting step:** The renal 1-alpha-hydroxylation is the most tightly regulated step in Vitamin D activation. 2. **Storage vs. Active form:** 25-hydroxycholecalciferol (Calcidiol) has the longest half-life; 1,25-dihydroxycholecalciferol (Calcitriol) is the most potent. 3. **Sarcoidosis Connection:** While the lungs aren't part of normal metabolism, in granulomatous diseases like Sarcoidosis, alveolar macrophages can express 1-alpha-hydroxylase, leading to hypercalcemia. 4. **Enzyme Deficiency:** Deficiency of 1-alpha-hydroxylase leads to **Vitamin D Dependent Rickets Type 1**.

Q: An individual with megaloblastic anemia is found to have a significant folate deficiency. Erythropoiesis is hampered in this patient due to his inability to perform which type of enzymatic reaction?

Methylation. **Explanation:** The correct answer is **Methylation**. Folate (Vitamin B9) in its active form, **Tetrahydrofolate (THF)**, serves as a carrier of one-carbon units (methyl, methylene, methenyl, formyl, and formimino groups). In the context of erythropoiesis, folate is essential for the synthesis of **dTMP (deoxythymidine monophosphate)** from dUMP. This reaction, catalyzed by *thymidylate synthase*, requires the transfer of a methyl group from N5,N10-methylene THF. A deficiency in folate leads to impaired DNA synthesis, causing "nuclear-cytoplasmic asynchrony" where the nucleus matures slower than the cytoplasm, resulting in **megaloblastic anemia**. Additionally, the conversion of homocysteine to methionine requires the transfer of a methyl group from N5-methyl THF (the "methyl trap" link with Vitamin B12). **Why other options are incorrect:** * **Acyl transfer:** This is primarily the function of **Coenzyme A (Vitamin B5)** and Thiamine (B1). * **Carboxylation:** This involves the addition of $CO_2$, a process dependent on **Biotin (Vitamin B7)** (e.g., Pyruvate carboxylase). * **Decarboxylation:** This is typically mediated by **Pyridoxal Phosphate (PLP/Vitamin B6)** or **Thiamine Pyrophosphate (TPP/Vitamin B1)**. **High-Yield Clinical Pearls for NEET-PG:** * **FIGLU Excretion Test:** Histidine loading leads to increased Formiminoglutamate (FIGLU) in urine in folate deficiency. * **The Methyl Trap Hypothesis:** Vitamin B12 deficiency leads to a functional folate deficiency because folate remains trapped as N5-methyl THF, unable to be recycled. * **Drug Link:** **Methotrexate** inhibits *Dihydrofolate Reductase (DHFR)*, preventing the regeneration of THF, thus mimicking folate deficiency.

Q: What is the biochemical role of vitamin K in the post-translational modification of clotting factors?

Carboxylation. **Biochemical Explanation:** Vitamin K serves as an essential cofactor for the enzyme **gamma-glutamyl carboxylase**. This enzyme catalyzes the addition of a carboxyl group ($CO_2$) to specific **glutamic acid (Glu)** residues on the N-terminal end of clotting factors. This post-translational modification converts them into **gamma-carboxyglutamic acid (Gla)** residues. The addition of this second carboxyl group gives the proteins a strong negative charge, allowing them to bind **Calcium ($Ca^{2+}$) ions**. This calcium binding acts as a "bridge," enabling the clotting factors to anchor onto the negatively charged phospholipid membranes of activated platelets, which is a prerequisite for the coagulation cascade. **Analysis of Options:** * **A. Glycosylation:** This involves the addition of carbohydrates to proteins (e.g., in the Golgi apparatus) and is not mediated by Vitamin K. * **C. Acetylation:** This is the addition of an acetyl group (common in histone modification) and is unrelated to the activation of clotting factors. * **D. Phosphorylation:** This is the addition of a phosphate group by kinases, primarily used in signal transduction and enzyme regulation. **High-Yield Clinical Pearls for NEET-PG:** * **Vitamin K Dependent Factors:** Factors **II, VII, IX, X**, and Proteins **C and S**. * **Warfarin Mechanism:** It inhibits **Vitamin K Epoxide Reductase (VKOR)**, preventing the regeneration of active (reduced) Vitamin K, thereby inhibiting carboxylation. * **Lab Marker:** Prothrombin Time (PT) is the most sensitive marker for Vitamin K deficiency because Factor VII has the shortest half-life. * **Newborns:** They are born with sterile guts (no Vitamin K-producing bacteria) and low placental transfer, necessitating a prophylactic Vitamin K injection to prevent **Hemorrhagic Disease of the Newborn**.

Q: A 30-year-old chronically malnourished male presented with complaints of weakness, lassitude, anorexia, abdominal discomfort, diarrhea, apathy, lethargy, and mild disorientation. On examination, glossitis and dermatitis in sun-exposed areas were noted. All of the following enzymes use the above deficient vitamin as a coenzyme EXCEPT:

Transaminase. ### Explanation **Clinical Diagnosis: Pellagra (Vitamin B3 / Niacin Deficiency)** The patient presents with the classic "3 Ds" of Pellagra: **Dermatitis** (Casal’s necklace/sun-exposed areas), **Diarrhea**, and **Dementia** (lethargy, apathy, disorientation), along with glossitis. This indicates a deficiency of **Niacin (Vitamin B3)**, which serves as a precursor for the coenzymes **NAD+** and **NADP+**. **Why Transaminase is the Correct Answer:** Transaminases (e.g., ALT, AST) do not use Niacin. Instead, they require **Pyridoxal Phosphate (PLP)**, the active form of **Vitamin B6**, as a mandatory coenzyme for the transfer of amino groups. **Analysis of Incorrect Options (Enzymes that DO use Niacin):** * **Glyceraldehyde 3-phosphate dehydrogenase:** A key enzyme in glycolysis that requires **NAD+** as an electron acceptor to convert G3P to 1,3-bisphosphoglycerate. * **Beta-ketoacyl reductase:** A component of the Fatty Acid Synthase complex involved in lipogenesis; it requires **NADPH** as a reducing agent. * **Pyruvate dehydrogenase (PDH):** A multi-enzyme complex that converts pyruvate to Acetyl-CoA. It requires five cofactors: Thiamine (B1), Riboflavin (B2), **Niacin (B3 as NAD+)**, Pantothenic acid (B5), and Lipoic acid. **High-Yield Clinical Pearls for NEET-PG:** * **Precursor:** Niacin can be synthesized from the amino acid **Tryptophan** (60 mg Tryptophan = 1 mg Niacin). * **Hartnup Disease:** Defective transport of neutral amino acids (Tryptophan) leading to pellagra-like symptoms. * **Carcinoid Syndrome:** Increased tryptophan metabolism into serotonin leads to secondary niacin deficiency. * **Corn/Maize Diets:** Low in tryptophan and contains "niacytin" (bound niacin), often leading to Pellagra in endemic areas.

Q: Folinic acid is:

5-formyl tetrahydrofolate. ### **Explanation** **1. Why Option A is Correct:** Folinic acid, also known as **Leucovorin** or Citrovorum factor, is the chemically stable derivative of folic acid. Structurally, it is **5-formyl tetrahydrofolate (5-formyl-THF)**. Unlike dietary folic acid, which requires the enzyme Dihydrofolate Reductase (DHFR) to be converted into its active form (THF), folinic acid is already a reduced form of folate. This allows it to bypass the DHFR-mediated step and directly enter the folate pool to support DNA synthesis. **2. Why the Other Options are Incorrect:** * **Option B & D:** Dihydrofolate (DHF) is the partially reduced form of folate. Folinic acid is a derivative of the fully reduced form, **Tetrahydrofolate (THF)**. Any option containing "dihydrofolate" is structurally incorrect for folinic acid. * **Option C:** N5, N10-methylene THF is a specific intermediate in the folate cycle used primarily by the enzyme thymidylate synthase. While it is a form of active folate, it is not the chemical name for Folinic acid/Leucovorin. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Leucovorin Rescue:** It is used to "rescue" normal cells from the toxicity of high-dose **Methotrexate** (a DHFR inhibitor). Since Methotrexate blocks the production of THF, providing 5-formyl-THF bypasses the block. * **5-Fluorouracil (5-FU) Potentiation:** In colorectal cancer treatment, Folinic acid is given with 5-FU. It stabilizes the binding of 5-FU to thymidylate synthase, enhancing the drug's cytotoxic effect. * **Methanol Toxicity:** It is used to enhance the metabolism of formate to CO₂ and water. * **Note:** Do not confuse Folinic acid with **Folic acid** (Vitamin B9) or **Folnic acid** (an older term for the same).

Q: Folate trap occurs due to the deficiency of which vitamin?

Vitamin B12. ### Explanation **The Correct Answer: Vitamin B12 (Cobalamin)** The "Folate Trap" hypothesis explains why Vitamin B12 deficiency leads to a functional folate deficiency. In the body, **N5-methyl tetrahydrofolate (N5-methyl THF)** is the major storage form of folate. To be reused for DNA synthesis, it must transfer its methyl group to homocysteine to form methionine. This reaction is catalyzed by the enzyme **Methionine Synthase**, which requires **Vitamin B12** as an essential cofactor. When Vitamin B12 is deficient: 1. The methyl group cannot be removed from N5-methyl THF. 2. Folate remains "trapped" in the N5-methyl form, which is metabolically inactive. 3. This leads to a shortage of other folate derivatives (like N5, N10-methylene THF) required for dTMP and DNA synthesis, resulting in **Megaloblastic Anemia**. --- ### Why the Other Options are Incorrect: * **A. Thiamine (B1):** Acts as a cofactor for oxidative decarboxylation (e.g., Pyruvate Dehydrogenase). Deficiency causes Beriberi or Wernicke-Korsakoff syndrome, not folate trapping. * **B. Biotin (B7):** Involved in carboxylation reactions (e.g., Pyruvate carboxylase). Deficiency leads to dermatitis and alopecia. * **C. Folic acid (B9):** While the trap involves folate, the *cause* of the trap is the absence of B12. Supplementing folate can bypass the trap and treat the anemia, but it will not fix the underlying B12 deficiency (risking neurological damage). --- ### High-Yield NEET-PG Pearls: * **The "Methyl-Folate Trap"** explains why B12 deficiency causes macrocytic anemia. * **Biochemical Marker:** In B12 deficiency, both **Homocysteine** and **Methylmalonic Acid (MMA)** levels are elevated. In pure folate deficiency, only Homocysteine is elevated. * **Clinical Warning:** Giving high doses of folate to a B12-deficient patient corrects the anemia but worsens the **Subacute Combined Degeneration (SCD)** of the spinal cord.

Question 1

Which of the following is NOT seen in hypervitaminosis A?

Accepted Answer

Polyuria

Answer

Alopecia

Answer

Pseudotumor cerebri

Answer

Hyperlipidemia

Question 2

How many mg of Tryptophan are required to produce 1 mg of Niacin?

Accepted Answer

60

Answer

22

Answer

37

Answer

55

Question 3

Which of the following acts as a cofactor after its modification?

Accepted Answer

Pantothenic acid

Answer

Vitamin C

Answer

Biotin

Answer

Zinc

Question 4

Which of the following does not have a role in regulating Vitamin D metabolism?

Accepted Answer

Lungs

Answer

Liver

Answer

Kidney

Answer

Skin

Question 5

An individual with megaloblastic anemia is found to have a significant folate deficiency. Erythropoiesis is hampered in this patient due to his inability to perform which type of enzymatic reaction?

Accepted Answer

Methylation

Answer

Acyl transfer

Answer

Carboxylation

Answer

Decarboxylation

Question 6

What is the biochemical role of vitamin K in the post-translational modification of clotting factors?

Accepted Answer

Carboxylation

Answer

Glycosylation

Answer

Acetylation

Answer

Phosphorylation

Question 7

A 30-year-old chronically malnourished male presented with complaints of weakness, lassitude, anorexia, abdominal discomfort, diarrhea, apathy, lethargy, and mild disorientation. On examination, glossitis and dermatitis in sun-exposed areas were noted. All of the following enzymes use the above deficient vitamin as a coenzyme EXCEPT:

Accepted Answer

Transaminase

Answer

Glyceraldehyde 3-phosphate dehydrogenase

Answer

Beta-ketoacyl reductase

Answer

Pyruvate dehydrogenase

Question 8

Folinic acid is:

Accepted Answer

5-formyl tetrahydrofolate

Answer

5-formyl dihydrofolate

Answer

N5, N10-methylene tetrahydrofolate

Answer

N5, N10-methylene dihydrofolate

Question 9

Thiamine level is best monitored by?

Accepted Answer

Transketolase level in blood

Answer

Thiamine level in blood

Answer

G6PD activity

Answer

Reticulocytosis

Question 10

Folate trap occurs due to the deficiency of which vitamin?

Accepted Answer

Vitamin B12

Answer

Thiamine

Answer

Biotin

Answer

Folic acid

Vitamins and Coenzymes — MCQs

Vitamins and Coenzymes — MCQs

On this page

Practice by Chapter

Want unlimited practice?